Endres, Dominique http://orcid.org/0000-0001-7322-1195
Meixensberger, Sophie
Dersch, Rick
Feige, Bernd http://orcid.org/0000-0002-9436-1258
Stich, Oliver
Venhoff, Nils
Matysik, Miriam
Maier, Simon J.
Michel, Maike
Runge, Kimon
Nickel, Kathrin
Urbach, Horst
Domschke, Katharina
PrĂ¼ss, Harald http://orcid.org/0000-0002-8283-7976
Tebartz van Elst, Ludger
Article History
Received: 25 April 2020
Revised: 12 July 2020
Accepted: 22 July 2020
First Online: 12 August 2020
Change Date: 1 October 2020
Change Type: Update
Change Details: The original HTML version of this Article was updated shortly after publication to add the Projekt DEAL funding acknowledgement.
Conflict of interest
: D.E.: None. S.M.: None. B.F.: None. R.D.: Lecture fees from Roche and travel grants from Biogen. O.S.: None. N.V.: Advisory boards, lectures, and travel grants from Roche. S.M.: None. M.Ma.: None. M.Mi.: None. K.R.: None. K.N.: None. H.U.: Shareholder of the Veobrain: K.D.: Steering Committee Neurosciences, Janssen. H.P.: None. L.T.v.E.: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics.